The animal vaccine is defined as an animal healthcare product, used to immunize domestic livestock, poultry and wild animal. It is a component of a larger field of medicine called veterinary biologics (VB). Animal vaccines are essential to enhance the welfare of the animal and reduce the monetary loss of the pet owners. Animal vaccine products help in prevention of animal diseases, increase food productivity, and avoid transmission of zoonotic and foodborne infections to humans. It aims to develop immunity in animals by stimulating the immune system with the help of either natural immunogenic components or non-pathogenic organisms. Thus, the vaccines help protect animal health by immunizing against any particular disease such as contagious, and infectious disease.

๐‹๐ข๐ฌ๐ญ ๐จ๐Ÿ ๐Š๐ž๐ฒ ๐๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ :

  • AniCon Labor Gmbh
  • Boehringer Ingelheim International GmbH
  • Cargill Animal Nutrition
  • Ceva Sante Animale
  • Hygieia Biological Laboratories
  • Intas Pharmaceutical Ltd.
  • Merck KGAA
  • Romvac Company S.A
  • Sanofi
  • SavaVet
  • Vaxxinova Gmbh
  • Virbac S.A
  • Vivaldis
  • Zoetis

๐ƒ๐จ๐ฐ๐ง๐ฅ๐จ๐š๐ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ

๐Š๐„๐˜ ๐…๐ˆ๐๐ƒ๐ˆ๐๐†๐’ ๐Ž๐… ๐“๐‡๐„ ๐’๐“๐”๐ƒ๐˜

  • By type, the attenuated vaccines segment was the highest contributor to the market in 2020.
  • On the basis of animal type, the companion animals segment dominated the market in 2020, and is expected to continue this trend during the forecast period.
  • Depending on valence, the multivalent segment was the highest contributor to the market in 2020.
  • Country wise, India garnered the largest revenue share in 2020, and is anticipated to grow at the highest CAGR during the forecast period.

๐—–๐—ผ๐˜ƒ๐—ถ๐—ฑ-๐Ÿญ๐Ÿต ๐—ฆ๐—ฐ๐—ฒ๐—ป๐—ฎ๐—ฟ๐—ถ๐—ผ:

The COVID-19 outbreak is anticipated to have a negative impact on the growth of the India, Bangladesh, Sri Lanka, Nepal animal vaccine market. The pandemic has greatly affected veterinary revenue of hospitals and clinics, owing to decline in number of visits amid nationwide lockdowns along with changing animal healthcare approach for providing care to emergency cases and critically ill animals. A huge number of clinics and hospitals across the globe were restructured to increase the hospital capacity for the patient diagnosed with COVID-19. Various veterinary organizations have recommended limiting patient care for acutely ill animals and emergencies, rescheduling annual exams, and elective procedures such as vaccinations. Therefore, this factor is estimated to drag the animal vaccines market growth rate over next couple of months. In addition, the pandemic has lowered the purchasing power of farm and pet owners. Moreover, several manufacturers are facing drawbacks as the market growth rate decreased from the onset of pandemic and are currently facing interruptions in supply chain activities.

๐…๐จ๐ซ ๐๐ฎ๐ซ๐œ๐ก๐š๐ฌ๐ž ๐ˆ๐ง๐ช๐ฎ๐ข๐ซ๐ฒ

The India, Bangladesh, Sri Lanka, Nepal Animal Vaccine market is segmented on the basis of type, animal type, valence, and country. On the basis of type, the market is divided into attenuated vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, recombinant vaccines, and DNA Vaccines. The attenuated vaccines segment dominated the market in 2020, and this trend is expected to continue during the forecast period, owing to advancement in R&D activities in animal healthcare sector, and increase in prevalence of infectious disease in animal.

Depending on animal type, the market is classified into companion vaccine, and poultry. The poultry segment exhibited the highest growth in 2020, and this trend is expected to continue during the forecast period, owing to increase in incidence of poultry population, surge in need for milk, meat and egg, and increase in demand for animal healthcare. By valence, the market is classified into monovalent, and multivalent. The multivalent segment acquired the top position in the market in 2020, and this trend is expected to continue during the forecast period, owing to increase in demand for polyvalent vaccine, and rise in prevalence of disease in animal.

๐—š๐—ฒ๐˜ ๐——๐—ฒ๐˜๐—ฎ๐—ถ๐—น๐—ฒ๐—ฑ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of โ€œMarket Research Reportsโ€ and โ€œBusiness Intelligence Solutions.โ€ AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.


David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975

Leave a comment

Your email address will not be published. Required fields are marked *